相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of neoantigens for individualized therapeutic cancer vaccines
Franziska Lang et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Revisiting the role of CD4+T cells in cancer immunotherapy-new insights into old paradigms
Rong En Tay et al.
CANCER GENE THERAPY (2021)
Recent developments of RNA-based vaccines in cancer immunotherapy
Elnaz Faghfuri et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2021)
Self-amplifying RNA vaccines for infectious diseases
Kristie Bloom et al.
GENE THERAPY (2021)
Strategies in DNA vaccine for melanoma cancer
Tayebeh Rezaei et al.
PIGMENT CELL & MELANOMA RESEARCH (2021)
Granulocyte macrophage colony-stimulating factor has come of age: From a vaccine adjuvant to antiviral immunotherapy
Maria Petrina et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2021)
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
Stephen A. Boorjian et al.
LANCET ONCOLOGY (2021)
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma
Zhuting Hu et al.
NATURE MEDICINE (2021)
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Eryn Blass et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
Myeloid and plasmacytoid dendritic cell combined vaccines loaded with heat-treated tumor cell lysates enhance antitumor activity in murine lung cancer
Huiguo Chen et al.
ONCOLOGY LETTERS (2021)
Recombinant protein vaccines, a proven approach against coronavirus pandemics
Jeroen Pollet et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary Analysis
Timothy J. Vreeland et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Xiaoqi Mao et al.
MOLECULAR CANCER (2021)
mRNA vaccine for cancer immunotherapy
Lei Miao et al.
MOLECULAR CANCER (2021)
Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy
Valeria Morante et al.
VIRUSES-BASEL (2021)
Clinical and Immunologic Responses to a B-Cell Epitope Vaccine in Patients with HER2/neu-Overexpressing Advanced Gastric Cancer-Results from Phase Ib Trial IMU.ACS.001
Ursula Wiedermann et al.
CLINICAL CANCER RESEARCH (2021)
mRNA therapeutics in cancer immunotherapy
Jan D. Beck et al.
MOLECULAR CANCER (2021)
Multicenter, Open-Label, Phase I Study of DSP-7888 Dosing Emulsion in Patients with Advanced Malignancies
Alexander Spira et al.
TARGETED ONCOLOGY (2021)
Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB-IVM1c melanoma
Josep Malvehy et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
CpG-Based Nanovaccines for Cancer Immunotherapy
Wenqiang Chen et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
Personalized DNA neoantigen vaccine in combination with plasmid IL-12 and pembrolizumab for the treatment of patients with advanced hepatocellular carcinoma.
Mark Yarchoan et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Long term results from a phase 1 trial of GEN-009, a personalized neoantigen vaccine, combined with PD-1 inhibition in advanced solid tumors.
Maura L. Gillison et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study
Otavio Ranzani et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
DC-Derived Exosomes for Cancer Immunotherapy
Yi Yao et al.
CANCERS (2021)
Therapeutic cancer vaccines
Mansi Saxena et al.
NATURE REVIEWS CANCER (2021)
Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion
Suchit Jhunjhunwala et al.
NATURE REVIEWS CANCER (2021)
The Changing Landscape of Therapeutic Cancer Vaccines-Novel Platforms and Neoantigen Identification
Jessica Jou et al.
CLINICAL CANCER RESEARCH (2021)
Adenovirus Vectors: Excellent Tools for Vaccine Development
Jun Chang
IMMUNE NETWORK (2021)
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Filippo Veglia et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression
Reem Saleh et al.
SEMINARS IN CANCER BIOLOGY (2020)
A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity
Tim Beissert et al.
MOLECULAR THERAPY (2020)
A Phase II, Prospective, Randomized, Multicenter, Open-Label Study of GX-188E, an HPV DNA Vaccine, in Patients with Cervical Intraepithelial Neoplasia 3
Youn Jin Choi et al.
CLINICAL CANCER RESEARCH (2020)
Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response
Sergio Linares-Fernandez et al.
TRENDS IN MOLECULAR MEDICINE (2020)
A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes
Srinivas Ramishetti et al.
ADVANCED MATERIALS (2020)
The challenge and prospect of mRNA therapeutics landscape
Yuhua Weng et al.
BIOTECHNOLOGY ADVANCES (2020)
Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B
Wenjun Wang et al.
NATURE NANOTECHNOLOGY (2020)
An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors
Katharina Reinhard et al.
SCIENCE (2020)
TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma
Brenda De Keersmaecker et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Tumor-Associated Macrophages: Recent Insights and Therapies
Jiawei Zhou et al.
FRONTIERS IN ONCOLOGY (2020)
Squaramides and Ureas: A Flexible Approach to Polymerase-Compatible Nucleic Acid Assembly
Arun Shivalingam et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
HPV vaccination and cancer prevention
A. Athanasiou et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2020)
Computational Prediction and Validation of Tumor-Associated Neoantigens
Vladimir Roudko et al.
FRONTIERS IN IMMUNOLOGY (2020)
Phase I trial of personalized mRNA vaccine encoding neoantigen in patients with advanced digestive system neoplasms.
Xianbao Zhan et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver
Lei Miao et al.
NATURE COMMUNICATIONS (2020)
Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma
Lihong Wang-Bishop et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Recent advances in mRNA vaccine technology
Norbert Pardi et al.
CURRENT OPINION IN IMMUNOLOGY (2020)
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases
Yanina Jansen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
Jesus Zepeda-Cervantes et al.
FRONTIERS IN IMMUNOLOGY (2020)
cGAS-STING, an important pathway in cancer immunotherapy
Minlin Jiang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Oncolytic viruses for cancer immunotherapy
Otto Hemminki et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Ugur Sahin et al.
NATURE (2020)
Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer
Erika J. Crosby et al.
CLINICAL CANCER RESEARCH (2020)
mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
Gal Cafri et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Dendritic cell biology and its role in tumor immunotherapy
Yingying Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine
Keven Lothert et al.
SCIENTIFIC REPORTS (2020)
Dual-Antigen-Loaded Hepatitis B Virus Core Antigen Virus-like Particles Stimulate Efficient Immunotherapy Against Melanoma
Keman Cheng et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial
Jin Won Youn et al.
LANCET ONCOLOGY (2020)
Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity
Iuliia Efimova et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Detection of immunogenic cell death and its relevance for cancer therapy
Jitka Fucikova et al.
CELL DEATH & DISEASE (2020)
Dendritic cells in cancer immunology and immunotherapy
Stefanie K. Wculek et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Dendritic cell targeted Ccl3-and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site
Anna Lysen et al.
SCIENTIFIC REPORTS (2019)
A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge
Elizabeth K. Duperret et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer
Alexandros Papachristofilou et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Turning the corner on therapeutic cancer vaccines
Robert E. Hollingsworth et al.
NPJ VACCINES (2019)
Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial
Elizabeth A. Mittendorf et al.
CLINICAL CANCER RESEARCH (2019)
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
Hyun Cheol Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors.
Howard A. Burris et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
Alessandra Lopes et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
Kalijn F. Bol et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Studying interactions between dendritic cells and T cells in vivo
Aleksey Chudnovskiy et al.
CURRENT OPINION IN IMMUNOLOGY (2019)
Trial watch: dendritic cell vaccination for cancer immunotherapy
Jenny Sprooten et al.
ONCOIMMUNOLOGY (2019)
The evolving landscape of 'next-generation' immune checkpoint inhibitors: A review
Luca Mazzarella et al.
EUROPEAN JOURNAL OF CANCER (2019)
Neoantigen vaccine: an emerging tumor immunotherapy
Miao Peng et al.
MOLECULAR CANCER (2019)
Radiation as an In Situ Auto-Vaccination: Current Perspectives and Challenges
Taichiro Goto
VACCINES (2019)
Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment
Li Yang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Vaccine-Induced Memory CD8+ T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study
Erika J. Crosby et al.
CLINICAL CANCER RESEARCH (2019)
CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
Bagher Farhood et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Actively personalized vaccination trial for newly diagnosed glioblastoma
Norbert Hilf et al.
NATURE (2019)
FTSJ3 is an RNA 2′-O-methyltransferase recruited by HIV to avoid innate immune sensing
Mathieu Ringeard et al.
NATURE (2019)
MDSC; the Most Important Cell You Have Never Heard Of
R. J. Tesi
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies
Jia Yang et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Reduced Breast Tumor Growth after Immunization with a Tumor-Restricted MUC1 Glycopeptide Conjugated to Tetanus Toxoid
Natascha Stergiou et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine
Victoria D. Turubanova et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Tertiary lymphoid structures in the era of cancer immunotherapy
Catherine Sautes-Fridman et al.
NATURE REVIEWS CANCER (2019)
Cooperation of Oligodeoxynucleotides and Synthetic Molecules as Enhanced Immune Modulators
Shireen Niger et al.
FRONTIERS IN NUTRITION (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Blocking CTLA-4 while priming with a whole cell vaccine reshapes the oligoclonal T cell infiltrate and eradicates tumors in an orthotopic glioma model
Cameron S. Field et al.
ONCOIMMUNOLOGY (2018)
Antitumor Humoral and T Cell Responses by Mucin-1 Conjugates of Bacteriophage Q beta in Wild-type Mice
Zhaojun Yin et al.
ACS CHEMICAL BIOLOGY (2018)
Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines
Stephen J. Russell et al.
CANCER CELL (2018)
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
Linda M. Liau et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
mRNA vaccines - a new era in vaccinology
Norbert Pardi et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Personalized vaccines for cancer immunotherapy
Ugur Sahin et al.
SCIENCE (2018)
YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity
Xuhao Ni et al.
CANCER DISCOVERY (2018)
PD-L1 checkpoint inhibition and anti-CTLA-4 whole tumor cell vaccination counter adaptive immune resistance: A mouse neuroblastoma model that mimics human disease
Priya Srinivasan et al.
PLOS MEDICINE (2018)
Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification
Sriram Vaidyanathan et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Sanjeev Mariathasan et al.
NATURE (2018)
Acetylation of Cytidine in mRNA Promotes Translation Efficiency
Daniel Arango et al.
CELL (2018)
Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes
Daniel B. Graham et al.
NATURE MEDICINE (2018)
Oncolytic virus immunotherapy: future prospects for oncology
Junaid Raja et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Re-induction using whole cell melanoma vaccine genetically modified to melanoma stem cells-like beyond recurrence extends long term survival of high risk resected patients - updated results
Jacek Mackiewicz et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Heat shock protein peptide complex-96 vaccination for newly diagnosed glioblastoma: a phase I, single-arm trial
Nan Ji et al.
JCI INSIGHT (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Zhuting Hu et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Integrating oncolytic viruses in combination cancer immunotherapy
Praveen K. Bommareddy et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Immunotherapy against cancer-related viruses
Haruko Tashiro et al.
CELL RESEARCH (2017)
Emerging experience with meningococcal serogroup B protein vaccines
Daniela Toneatto et al.
EXPERT REVIEW OF VACCINES (2017)
Danger signals: Chemotherapy enhancers?
Thaiz Rivera Vargas et al.
IMMUNOLOGICAL REVIEWS (2017)
Myeloid-derived suppressor cellsa new therapeutic target to overcome resistance to cancer immunotherapy
Jason A. Chesney et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
Yuchen Fan et al.
NANO LETTERS (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
The problem with neoantigen prediction
NATURE BIOTECHNOLOGY (2017)
Short poly(A) tails are a conserved feature of highly expressed genes
Sarah Azoubel Lima et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Major findings and recent advances in virus like particle (VLP)-based vaccines
Mona O. Mohsen et al.
SEMINARS IN IMMUNOLOGY (2017)
Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo
Stephan Halle et al.
TRENDS IN IMMUNOLOGY (2017)
Short poly(A) tails are a conserved feature of highly expressed genes
Sarah Azoubel Lima et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2017)
Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
John J. Suschak et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma
Alessandra Lopes et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2017)
Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC
Caroline Tosch et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
The Importance of Immunization in Cancer Prevention, Treatment, and Survivorship
Elizabeth M. Ward et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
Edward W. Roberts et al.
CANCER CELL (2016)
Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma
Robert A. Fenstermaker et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Dendritic Cell-Based Immunotherapy: State of the Art and Beyond
Kalijn F. Bol et al.
CLINICAL CANCER RESEARCH (2016)
DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy
Angeliki Tiptiri-Kourpeti et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF
Tsuguhide Takeshima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Forced co-expression of IL-21 and IL-7 in whole-cell cancer vaccines promotes antitumor immunity
Yang-Zhuo Gu et al.
SCIENTIFIC REPORTS (2016)
Whole cell vaccination using immunogenic cell death by an oncolytic adenovirus is effective against a colorectal cancer model
Tomoki Yamano et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
Adjuvants for peptide-based cancer vaccines
Hiep Khong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study
Katy J. McCann et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Therapeutic cancer vaccines
Cornelis J. M. Melief et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs
Kevin J. Kauffman et al.
NANO LETTERS (2015)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Oncolytic viruses: a new class of immunotherapy drugs
Howard L. Kaufman et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Mutation-Specific T Cells for Immunotherapy of Gliomas
Cornelis J. M. Melief
NEW ENGLAND JOURNAL OF MEDICINE (2015)
An Ebola whole-virus vaccine is protective in nonhuman primates
Andrea Marzi et al.
SCIENCE (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
Neoepitopes of Cancers: Looking Back, Looking Ahead
Pramod K. Srivastava
CANCER IMMUNOLOGY RESEARCH (2015)
Immunogenicity of necrotic cell death
Jaba Gamrekelashvili et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS
Yoshihiro Yoshitake et al.
CLINICAL CANCER RESEARCH (2015)
A multiepitope of XBP1, CD138 and CS1 peptides induces myeloma-specific cytotoxic T lymphocytes in T cells of smoldering myeloma patients
J. Bae et al.
LEUKEMIA (2015)
TGF-beta Activation and Function in Immunity
Mark A. Travis et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Cap-dependent translation initiation factor, eIF4E, is the target for Ouabain-mediated inhibition of HIF-1α
Ji Cao et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients
Sergio Occhipinti et al.
CLINICAL CANCER RESEARCH (2014)
Safety and Preliminary Evidence of Biologic Efficacy of a Mammaglobin-A DNA Vaccine in Patients with Stable Metastatic Breast Cancer
Venkataswarup Tiriveedhi et al.
CLINICAL CANCER RESEARCH (2014)
Adenovirus-Based Vaccines for Fighting Infectious Diseases and Cancer: Progress in the Field
Dragomira Majhen et al.
HUMAN GENE THERAPY (2014)
Macrophages: Supportive cells for tissue repair and regeneration
Benedicte Chazaud
IMMUNOBIOLOGY (2014)
Therapeutic vaccines for cancer: an overview of clinical trials
Ignacio Melero et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
mRNA-based therapeutics - developing a new class of drugs
Ugur Sahin et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccination for Recurrent Glioblastoma: A Phase II, Single Arm Trial
Orin Bloch et al.
NEURO-ONCOLOGY (2014)
In vitro and in vivo Repair Activities of Undifferentiated and Classically and Alternatively Activated Macrophages
Zoe Enderlin Vaz da Silva et al.
PATHOBIOLOGY (2014)
Increased Generation of HIV-1 gp120-Reactive CD8+ T Cells by a DNA Vaccine Construct Encoding the Chemokine CCL3
Inger Oynebraten et al.
PLOS ONE (2014)
Xenogeneic therapeutic cancer vaccines as breakers of immune tolerance for clinical application: To use or not to use?
Marius M. Strioga et al.
VACCINE (2014)
From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation
Paola Italiani et al.
FRONTIERS IN IMMUNOLOGY (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
S. Wilgenhof et al.
ANNALS OF ONCOLOGY (2013)
Dual Blockade of PD-1 and CTLA-4 Combined with Tumor Vaccine Effectively Restores T-Cell Rejection Function in Tumors
Jaikumar Duraiswamy et al.
CANCER RESEARCH (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer
Hiroyuki Suzuki et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Fusion of Hsp70 to Mage-a1 enhances the potency of vaccine-specific immune responses
Juhong Jiang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Oral Vaccination With Adeno-associated Virus Vectors Expressing the Neu Oncogene Inhibits the Growth of Murine Breast Cancer
Jason C. Steel et al.
MOLECULAR THERAPY (2013)
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
Martin A. Maier et al.
MOLECULAR THERAPY (2013)
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Masaru Kanekiyo et al.
NATURE (2013)
Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
Yared Hailemichael et al.
NATURE MEDICINE (2013)
The intimate relationships of mRNA decay and translation
Bijoyita Roy et al.
TRENDS IN GENETICS (2013)
Challenges and advances towards the rational design of mRNA vaccines
Charlotte Pollard et al.
TRENDS IN MOLECULAR MEDICINE (2013)
DNA vaccine coding for the rhesus prostate specific antigen delivered by intradermal electroporation in patients with relapsed prostate cancer
Fredrik Eriksson et al.
VACCINE (2013)
Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients
Ryuji Okuyama et al.
ONCOIMMUNOLOGY (2013)
Vaccination against human papillomavirus
Claudia Figueiredo Mello
EINSTEIN-SAO PAULO (2013)
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo
Muthusamy Jayaraman et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
PEGylation of Proteins and Liposomes: a Powerful and Flexible Strategy to Improve the Drug Delivery
Paola Milla et al.
CURRENT DRUG METABOLISM (2012)
Technologies for enhanced efficacy of DNA vaccines
Fadi Saade et al.
EXPERT REVIEW OF VACCINES (2012)
Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin
Bijan Zakeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
T-Cell Tolerance: Central and Peripheral
Yan Xing et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer
Thomas A. Gardner et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Overcoming HLA restriction in clinical trials Immune monitoring of mRNA-loaded DC therapy
An M. T. Van Nuffel et al.
ONCOIMMUNOLOGY (2012)
Highly Specific Auto-Antibodies against Claudin-18 Isoform 2 Induced by a Chimeric HBcAg Virus-Like Particle Vaccine Kill Tumor Cells and Inhibit the Growth of Lung Metastases
Thorsten Klamp et al.
CANCER RESEARCH (2011)
DNA vaccines: an historical perspective and view to the future
Margaret A. Liu
IMMUNOLOGICAL REVIEWS (2011)
Adjuvants for Enhancing the Immunogenicity of Whole Tumor Cell Vaccines
Cheryl Lai-Lai Chiang et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2011)
A diverse range of gene products are effectors of the type I interferon antiviral response
John W. Schoggins et al.
NATURE (2011)
Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA
Katalin Kariko et al.
NUCLEIC ACIDS RESEARCH (2011)
RIG-I Detects Viral Genomic RNA during Negative-Strand RNA Virus Infection
Jan Rehwinkel et al.
CELL (2010)
DNA Vaccines: Developing New Strategies against Cancer
Daniela Fioretti et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Whole tumor antigen vaccines
Cheryl Lai-Lai Chiang et al.
SEMINARS IN IMMUNOLOGY (2010)
Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection
Florence Faurez et al.
VACCINE (2010)
Topical Imiquimod or Fluorouracil Therapy for Basal and Squamous Cell Carcinoma
W. Elliot Love et al.
ARCHIVES OF DERMATOLOGY (2009)
Optimized Peptide Vaccines Eliciting Extensive CD8 T-Cell Responses with Therapeutic Antitumor Effects
Hyun-Il Cho et al.
CANCER RESEARCH (2009)
AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
Arnaud M. Didierlaurent et al.
JOURNAL OF IMMUNOLOGY (2009)
STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
Hiroki Ishikawa et al.
NATURE (2009)
Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
Martijn S. Bijker et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant
Sylvia Adams et al.
JOURNAL OF IMMUNOLOGY (2008)
5′-triphosphate-dependent activation of PKR by RNAs with short stem-loops
Subba Rao Nallagatla et al.
SCIENCE (2007)
Steric stabilization of lipid/polymer particle assemblies by poly(ethylene glycol)-lipids
Julie Thevenot et al.
BIOMACROMOLECULES (2007)
CD8+ CTL priming by exact peptide epitopes in incomplete Freund's adjuvant induces a vanishing CTL response, whereas long peptides induce sustained CTL reactivity
Martijn S. Bijker et al.
JOURNAL OF IMMUNOLOGY (2007)
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming
Danila Valmori et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A phase I trial of pox PSA vaccines (PROSTVAC®-VF) with b7-1, ICAM-1, and LFA-3 co-stimulatory molecules (TRICOM™) in patients with prostate cancer -: art. no. 1
RS DiPaola et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
DA Thomas et al.
CANCER CELL (2005)
Suppression of RNA recognition by Toll-like receptors:: The impact of nucleoside modification and the evolutionary origin of RNA
K Karikó et al.
IMMUNITY (2005)
Vaccines in cancer:: GVAX®, a GM-CDF gene vaccine
John Nemunaitis
EXPERT REVIEW OF VACCINES (2005)
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes:: results of thefirst phase I clinical trial
B Escudier et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
A listing of human tumor antigens recognized by T cells: March 2004 update
L Novellino et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer
MA Morse et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
The implications of structured 5′ untranslated regions on translation and disease
BM Pickering et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2005)
Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation
Z Wang et al.
GENE THERAPY (2004)
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
F Heil et al.
SCIENCE (2004)
Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling
MA West et al.
SCIENCE (2004)
GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancer
J Nemunaitis
JOURNAL OF CONTROLLED RELEASE (2003)
Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity
AA Itano et al.
IMMUNITY (2003)
Poly(A)-binding proteins: multifunctional scaffolds for the post-transcriptional control of gene expression
DA Mangus et al.
GENOME BIOLOGY (2003)
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
L Alexopoulou et al.
NATURE (2001)
The dendritic cell and human cancer vaccines
RM Dallal et al.
CURRENT OPINION IN IMMUNOLOGY (2000)
分享论文
